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Objective: This study aimed to compare the quality of life in Siewert type II esophagogastric junctional
adenocarcinoma patients receiving either laparoscopic total gastrectomy or open total gastrectomy.
Methods: From Sep 1, 2008 to May 1, 2012, totally 204 consecutive patients with Siewert type II
esophagogastric junctional adenocarcinoma were involved in this retrospective study. Patients were
assigned to receive either laparoscopic total gastrectomy or open total gastrectomy. Details concerning
the postoperative outcomes and the quality of life questionnaire were collected and compared.
Results: Totally 104 patients were involved in the open gastrectomy group and 100 in the laparoscopic
gastrectomy group. No differences were noted between the groups in demographics, blood loss, anas-
tomotic leak, anastomotic stricture, hospital stay, reoperation and in-hospital mortality. Totally 188 cases
of patients (92.16%) responded to the questionnaire measures during the entire follow-up period,
including 93 (93%) in the laparoscopic group and 95 (91.35%) in the open group. The score of every scale
and item in laparoscopic group improved much more quickly comparing with the open group, suggesting
that patients in laparoscopic group recovered much more quickly than those in open group.
Conclusions: Laparoscopic total gastrectomy could lead to a signiﬁcant improvement of the short-term
beneﬁts for patients with esophagogastric junctional adenocarcinoma as compared with open group.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Esophagogastric junctional adenocarcinoma (EGJA) was consid-
ered as a challenging therapeutic problem with high morbidity
and poor prognosis.1 The incidence of Siewert type II EGJA has been
increasing in the world.2
Surgery is traditionally viewed as the most important treatment
for Siewert type II EGJA. In the past 2 decades, advances in EGJA
surgery have been remarkable. The most important goal in the
surgical treatment of EGJA is to perform an R0 resection.3 This goal
can be achieved by either laparoscopic total gastrectomy (LTG) or
open total gastrectomy.4 Laparoscopic surgery had many advan-
tages, such as reduced pain, fewer wound, and an earlier return to
normal activities, comparing with open surgery.5 In recent years, an
increasing number of patients with EGJA have been treated by LTG,
especially in Korea and Japan.5e7 However, LTG is not a very popular: þ86 29 82539041.
ciates Ltd. Published by Elsevier Ltprocedure for the treatment of EGJA because it is technically difﬁ-
cult given the scope of the wide range lymph node dissection
required. Although the number of single institution reports on LTG
has been increasing, there remain few reports comparing open total
gastrectomy and LTG for patients with EGJA.
This study has evaluated the short-term outcomes of LTG versus
open total gastrectomy for patients with Siewert type II EGJA. The
results clearly showed that LTG led to better short-term quality of
life than open esophagectomy did, with no compromise in the
quality of the resected specimen.
2. Materials and methods
2.1. Study design and patient characteristics
From Sep 1, 2008 to May 1, 2012, totally 204 consecutive patients (31e74 years
old) with Siewert type II EGJA were involved in this study. All of them underwent a
surgical resection at Bozhou Hospital and Xijing Hospital of Digestive Diseases, Xi’an,
China. Diagnosis and staging was established before surgery by esophagogas-
troduodenoscop and biopsies. In addition, computed tomography scans of the
thorax, abdomen and endoscopic ultrasonography were applied to exclude cases of
local extension, massive lymph invasion, or organic metastasis.d. All rights reserved.
Table 1
Clinical and pathological characteristics of EGJA patients.
Characteristics Open group (n ¼ 104) LTG group (n ¼ 100)
Age (years) 54.45  10.44 53.23  11.03
Sex
Male 76 71
Female 28 29
Body mass index(kg/m2) 24.35  1.24 24.13  2.31
Weight loss
<10% 90 (86.54%) 87(87%)
10% 14 (13.46%) 13 (13%)
ASA score
I 5 6
II 96 92
III 3 2
Differentiation status
Well differentiated 30 26
Moderately differentiated 35 33
Poorly differentiated 39 41
pTNM classiﬁcation
I 5 6
II 54 53
III 45 41
IV 0 0
EGJA, esophagogastric junctional adenocarcinoma; LTG, laparoscopic total gastrec-
tomy; ASA, American Society of Anesthesiologists.
Table 2
The outcomes of EGJA patients receiving open total gastrectomy or LTG.
Open group
(n ¼ 104)
LTG group
(n ¼ 100)
Intraoperative data
Operative time (min) 236.38  21.35 261.33  24.31
Blood loss (mL) 185.26  37.21 128.14  24.45
Total lymph nodes retrieved 19.15  5.21 19.24  7.31
Postoperative data
First ambulatory time (days) 1.97  0.47 1.29  0.35
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operation; (2) All patients had no history of previous abdominal surgery; (3) All the
patients had good performance status with The Eastern Cooperative Oncology
Group (ECOG) scores 0e1 before surgery. Exclusion criteria: (1) HIV-positive pa-
tients or pregnant women; (2) Patients with poor cardiopulmonary function; (3)
Patients without R0 resection; (4) patients with TNM IV stage or metastatic disease.
For quality assurance, the patients with Siewert type II EGJA were randomly
assigned via a computer-generated randomization sequence, in a 1:1 ratio, to receive
either laparoscopic total gastrectomy or open total gastrectomy. A prospective
database approved by our institutional review board was used to store and extract
patient data, including sex, age, marital status, body mass index (calculated as
weight in kilograms divided by height in meters squared), American Society of
Anesthesiologists (ASA) grade, operative time (skin incision to skin closure), blood
loss, pathology, clinical stage, hospital stay, perioperative morbidity and mortality,
etc. Data from this studywere evaluated according to the rules of the ethical board at
our institute. Informed consent was obtained from each participating patient, and
the ethics committee at Xijing Hospital, Xi’an, China, approved the study.
2.2. Perioperative treatment
Patients in both groups received similar preoperative treatment, including reg-
ular consultations by a physiotherapist, a pulmonologist and cardiologist. To prevent
surgeon bias, both procedureswere done by the same surgical group (four surgeons),
experienced in both open total gastrectomy and LTG procedures. The open operation
and LTG procedures with D2 lymph node dissection were described as previously.8,9
After surgery, all patients were admitted to the general surgical ward. From the
ﬁrst day after surgery, patients were encouraged to move out of bed after detuba-
tion. Enteral feeding was started on day 1 after surgery through a percutaneous
jejunostomy catheter. The amount of enteral nutrition was gradually increased if
there was no nausea, vomiting, abdominal distension, abdominal pain and diarrhea.
Upper gastrointestinal water-soluble contrast examination was performed on the
7th postoperative day to exam the integrity of the anastomosis. Diet was started
after conﬁrming anastomosis patency and the absence of leakage. Patients were
discharged when they were mobile, and could eat solid food.
2.3. Analysis of quality of life (QOL)
The esophageal-speciﬁc module (OES-18) and the quality of life questionnaire
(QLQ) C-30, developed by European Organization for Research and Treatment of
Cancer, were applied to compare the short-term QOL in two groups.10 The QLQ OES-
18 consisted of six single items (taste problem, swallowing saliva, dry mouth,
choking when swallowing, coughing and speech problem) and four symptom scales
(dysphagia, reﬂux, eating and esophageal pain). The QLQ-C30 includes one global
QOL scale, three general symptom scales (nausea and vomiting, fatigue and pain),
ﬁve functional scales (cognitive, physical, emotional, role and social), and six single-
item general symptom measures (dyspnea, constipation, insomnia, diarrhea appe-
tite loss, and ﬁnancial difﬁculties). All patients ﬁlled out the questionnaires before
operation and at the follow-up (1, 3, 5 and 8 weeks after operation) by out patient
consultant. Scores derived from the 2 questionnaires were transformed into a 0 to
100 scale according to the EORTC Scoring Manual.
2.4. Follow-up
All patients were followed up every 1 month for years 1 and 2, and annually
thereafter. All patients were contacted by telephone by one of two trained research
nurses.11
2.5. Statistical analysis
All collected data were tested for normality and presented as mean (SD) or
median, and were analyzed using Prism 5.0 software (GraphPad). The signiﬁcance of
differences from the control values was determined with Student’s t test or the c2
test. P < 0.05 was considered statistically signiﬁcant.Hospital stay (days) 9.15  1.51 7.32  1.23
Reoperations 1 0
Complications
In-hospital pulmonary infection 3 (2.88%) 0 (0%)
Anastomotic leakage 0 1(1%)
Anastomotic stricture 0 0
Arrhythmia 7(6.73%) 5(5%)
Wound infection 5(4.81%) 2(2%)
Mortality
30-day mortality 1(0.96%) 0 (0%)
In-hospital mortality 1 (0.96%) 0 (0%)
EGJA, esophagogastric junctional adenocarcinoma; LTG, laparoscopic total
gastrectomy.3. Results
3.1. Demographic characteristics
The clinicopathologic characteristics of the patients were sum-
marized in Table 1. A total of 204 patients with Siewert type II EGJA
were included in the study, including 100 cases in LTG group and
104 patients in the open group. The age, gender, sex, body mass
index, weight loss, ASA classiﬁcation, differentiation status and
tumor stage were similarly distributed between the two groups.3.2. Perioperative state
As Table 2 shown, the mean operating time, blood loss and
median lymph node harvest did not differ between the 2 groups.
The cervical anastomotic leakage occurred in 1 (1%) of the LTG
group, while zero (0%) in the open group, respectively. No patient
with anastomotic leakage underwent reoperation. One patient in
the open group underwent reoperation due to splenic bleeding. The
rate of anastomotic leakage, anastomotic stricture, reoperation and
other postoperative complications did not differ signiﬁcantly be-
tween groups. The 30-day postoperative mortality occurred in 1
patient in the open group due to pneumonia and respiratory failure,
while none in the LTG group.
3.3. Postoperative life quality
Totally 188 cases of patients (92.16%) responded to the
questionnaire measures, including 93 (93%) in the laparoscopic
Fig. 1. The global quality of life scores in patients receiving laparoscopic total gastrectomy (LTG group) and open total gastrectomy (open group). High scores represented better
quality of life.
Fig. 2. The physical functioning scores in patients receiving laparoscopic total gastrectomy (LTG group) and open total gastrectomy (open group). High scores represented better
physical function.
L. Hong et al. / International Journal of Surgery 11 (2013) 957e961 959
ORIGINAL RESEARCHgroup and 95 (91.35%) in the open group. In the assessment of
the QOL before operation, the scores of every scale and item
between the two groups were of no statistical difference. As
Figs. 1 and 2 shown, the mean scores of global QOL and physical
functioning in open group improved much more slowlyFig. 3. The fatigue symptom scores in patients receiving laparoscopic total gastrectomy (LTG
fatigue problem.comparing with the LTG group, suggesting that patients in
LTG group recovered much more quickly than those in open
group. The scores of fatigue scale and pain scale in LTG
group were persistently less than those in open group (Figs. 3
and 4).group) and open total gastrectomy (open group). High scores represented more severe
Fig. 4. The pain symptom scores in patients receiving laparoscopic total gastrectomy (LTG group) and open total gastrectomy (open group). High scores represented more severe
pain problem.
L. Hong et al. / International Journal of Surgery 11 (2013) 957e961960
ORIGINAL RESEARCH4. Discussion
Radical total gastrectomywithD2 lymphnodedissectionhas long
been the mainstay curative treatment for EGJA. Recently, LTG has
gainedwide acceptance as safe and feasiblemethod for treatment of
EGJA.12 Several studies have reported clinical advantages for LTG,
such as less pain, better cosmetic outcomes, faster bowel recovery,
shorter hospital stays, and improved quality of life in the period
following surgery.13e15 Due to the accumulation of surgical experi-
ence, LTG is no longer regarded as a difﬁcult procedure that can only
be performed by some experts, but rather a conventional procedure.
This study has investigated whether LTG had equivalent onco-
logic outcomes to that of open total gastrectomy for patients with
resectable Siewert type II EGJA. This objective was examined by
performing a comparison of cohorts of EGJA patients who under-
went LTG or open total gastrectomy. Themost important goal in the
surgical treatment of EGJA was to perform a complete D2 lymph
node dissection. Importantly, we noted no compromise in the
quality of the resected specimen and no signiﬁcant differences in
the number of lymph nodes retrieved. Basing on the principal of
achieving an equally successful oncologic resection and pathologic
staging, LTG was believed to be associated with at least an equal
morbidity rate as compared with conventional open approaches.
QOL referred to the patient’s self-reported perception of their
ability to live a useful and fulﬁlling life.16 QOL was considered as the
second relevant outcome measure to assess the cancer therapy by
the U.S. Food and Drug Administration.17 Evaluation of QOL seemed
particularly important for patients after total gastrectomy in view
of the extensive trauma and the poor prognosis. The data clearly
revealed that LTG could lead to better QOL. The postoperative
discomfort caused by the wound had a role on inhibiting the
postoperative recovery. LTG lead to few wound, thus resulting in a
better QOL than open gastrectomy did, with no compromise in the
quality of the resected specimen.
This study had several limitations. First, a single hospital-based
design might lead to an uncertain amount of selection bias. Second,
it was a retrospective research and the case capacity was not large.
And all thesemight introduce potential bias into the data. Third, the
survival data were incomplete.
Our study also had several strengths. Firstly, the results were
based on randomized series, which could reduce selection bias.
Second, the observed complication rates were minimally affected
by surgical inexperience. The four surgeons involved in this study
had considerable experience by undertaking at least 100 cases of
LTG or open total gastrectomy.In conclusion, LTG could result in a signiﬁcant improvement of
the short-term beneﬁts of patients with resectable Siewert type II
EGJA as compared with open total gastrectomy. Further random-
ized controlled trials studies were needed to investigate the long-
time survival and quality of life by follow-up study.
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